Zydus gets DCGI approval to commence Phase III clinical trials with Pegylated Interferon alpha-2b
In Phase II clinical trials, Pegylated Interferon alpha – 2b increased viral reduction and reduced the need for supplemental…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.